Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05585164 · ClinicalTrials.gov registry record · NA
Engage & Connect: A Psychotherapy for Postpartum Depression
A NA study of Postpartum Depression, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05585164: Recruiting NA study of Postpartum Depression, sponsored by Weill Medical College of Cornell University.
NCT05585164 is a NA study of Postpartum Depression that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 60 participants, below the 474-participant average among 47 other Postpartum Depression trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05585164, a NA study of Postpartum Depression, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized controlled trial compares a novel psychotherapy, Engage \& Connect, with a Symptom Review and Psychoeducation intervention, tailored to reduce postpartum depression. The study includes 9-weeks interventions, delivered remotely. It will examine changes in social isolation, processing of social rewards and depression severity over 9 weeks of treatment.
Primary Outcome
Measure of depression Severity. Scores range from 0 (no depression severity) to 30 (high depression severity)
Conditions Studied
Interventions
- BEHAVIORAL Symptom Review and Psychoeducation (SRP)
- BEHAVIORAL Engage & Connect (E&C)
Study Locations (1)
New York
- Weill Cornell Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2030-07 |
| Phase | NA |
What NCT05585164 shows while recruiting
NCT05585164 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 474-participant average among 47 other Postpartum Depression trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Postpartum Depression appearing as the primary indexed condition, and to 2 interventions - of which Symptom Review and Psychoeducation (SRP) is the first listed.
NCT05585164 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05585164 about?
NCT05585164 is a clinical study titled "Engage & Connect: A Psychotherapy for Postpartum Depression". This randomized controlled trial compares a novel psychotherapy, Engage \& Connect, with a Symptom Review and Psychoeducation intervention, tailored to reduce postpartum depression. The study includes 9-weeks interventions, delivered remotely. It will examine changes in social isolation, processing ...
What is the current status of trial NCT05585164?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-11-01. Estimated completion is 2030-07.
What conditions does trial NCT05585164 study?
This clinical trial studies the following conditions: Postpartum Depression.
What interventions are being tested in trial NCT05585164?
The interventions under investigation include: Symptom Review and Psychoeducation (SRP) (BEHAVIORAL), Engage & Connect (E&C) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05585164?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05585164 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05585164's enrollment target sits among peer trials
60 35th of 47 higher than 12 of 47 other Postpartum Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postpartum Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preventing Postpartum Depression in Immigrant Latinas
RECRUITING · NA
-
In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Maternal Mental Health Access - MaMa
RECRUITING · NA
-
The Mom and Infant Outcomes (MOMI) Study
RECRUITING · NA
-
Maternal Stress on Human Milk and Infant Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI